Ignite Creation Date:
2025-12-24 @ 4:26 PM
Ignite Modification Date:
2026-01-07 @ 10:49 AM
Study NCT ID:
NCT00318266
Status:
COMPLETED
Last Update Posted:
2017-08-25
First Post:
2006-04-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NMP22 Provides Improved Sensitivity in Detecting Bladder Cancers.
Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
R-05-885
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None